E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells.

Abstract:

:DDB2, a gene mutated in XPE patients, is involved in global genomic repair especially the repair of cyclobutane pyrimidine dimers (CPDs), and is regulated by p53 in human cells. We show that DDB2 is expressed in mouse tissues and demonstrate, using primary mouse epithelial cells, that mouse DDB2 is regulated by E2F transcription factors. Retinoblastoma (Rb), a tumor suppressor critical for the control of cell cycle progression, regulates E2F activity. Using Cre-Lox technology to delete Rb in primary mouse hepatocytes, we show that DDB2 gene expression increases, leading to elevated DDB2 protein levels. Furthermore, we show that endogenous E2F1 and E2F3 bind to DDB2 promoter and that treatment with E2F1-antisense or E2F1-small interfering RNA (siRNA) decreases DDB2 transcription, demonstrating that E2F1 is a transcriptional regulator for DDB2. This has consequences for global genomic repair: in Rb-null cells, where E2F activity is elevated, global DNA repair is increased and removal of CPDs is more efficient than in wild-type cells. Treatment with DDB2-siRNA decreases DDB2 expression and abolishes the repair phenotype of Rb-null cells. In summary, these results identify a new regulatory pathway for DDB2 by E2F, which does not require but is potentiated by p53, and demonstrate that DDB2 is involved in global repair in mouse epithelial cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Prost S,Lu P,Caldwell H,Harrison D

doi

10.1038/sj.onc.1210151

subject

Has Abstract

pub_date

2007-05-24 00:00:00

pages

3572-81

issue

24

eissn

0950-9232

issn

1476-5594

pii

1210151

journal_volume

26

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.

    abstract::During normal tumor growth and in response to some therapies, tumor cells experience acute or chronic deprivation of nutrients and oxygen and induce tumor vascularization. While this occurs predominately through sprouting angiogenesis, tumor cells have also been shown to directly contribute to vessel formation through...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.356

    authors: Langer EM,Kendsersky ND,Daniel CJ,Kuziel GM,Pelz C,Murphy KM,Capecchi MR,Sears RC

    更新日期:2018-02-22 00:00:00

  • A pancreatic cancer-specific expression profile.

    abstract::We present an approach making use of technology established in the context of the genome project to describe a pancreatic cancer-specific expression profile and to identify new potential disease genes or disease-associated-genes. By use of gridded arrays of pancreatic cancer cDNA libraries and differential hybridizati...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gress TM,Müller-Pillasch F,Geng M,Zimmerhackl F,Zehetner G,Friess H,Büchler M,Adler G,Lehrach H

    更新日期:1996-10-17 00:00:00

  • Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members.

    abstract::p53 is a tumour suppressor gene which functions as a transcription factor to upregulate genes for growth arrest and apoptosis following DNA damage. p53 mutations are associated with Li-Fraumeni and Li-Fraumeni like syndromes. Recently mutations of the oligomerization domain have been isolated from an LFS and an LFL fa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201974

    authors: Lomax ME,Barnes DM,Hupp TR,Picksley SM,Camplejohn RS

    更新日期:1998-08-06 00:00:00

  • Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference.

    abstract::Tumor necrosis factor alpha (TNF alpha) is a proinflammatory cytokine with important roles in regulating inflammatory responses as well as cell cycle proliferation and apoptosis. Although TNFalpha stimulates apoptosis, it also activates the transcription factor NF-kappa B, and studies have shown that inhibition of NF-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206262

    authors: Zhou A,Scoggin S,Gaynor RB,Williams NS

    更新日期:2003-04-03 00:00:00

  • Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.

    abstract::Homeodomain interacting protein kinase-2 (HIPK2) is a member of the HIPK family of stress-responsive kinases that modulates cell growth, apoptosis, proliferation and development. HIPK2 has several well-characterised tumour suppressor roles, but recent studies suggest it can also contribute to tumour progression, altho...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.221

    authors: Torrente L,Sanchez C,Moreno R,Chowdhry S,Cabello P,Isono K,Koseki H,Honda T,Hayes JD,Dinkova-Kostova AT,de la Vega L

    更新日期:2017-11-02 00:00:00

  • RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789.

    abstract::FGFR1 (fibroblast growth factor receptor 1) regulates many key cellular responses including proliferation, migration and differentiation through activation of signaling pathways. Irregularities in FGFR1 signaling have been implicated in several pathological conditions, including human cancer. In order to discover nove...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.425

    authors: Nadratowska-Wesolowska B,Haugsten EM,Zakrzewska M,Jakimowicz P,Zhen Y,Pajdzik D,Wesche J,Wiedlocha A

    更新日期:2014-10-02 00:00:00

  • Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.

    abstract::Mouse plasmacytomas induced by pristane oil alone, or in combination with Abelson murine leukemia virus (A-MuLV), regularly carry one of three alternative chromosomal translocations that juxtapose c-myc to immunoglobulin heavy- or light-chain loci. E mu-c-myc transgenic mice develop translocation-free plasmacytomas af...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wang Y,Sugiyama H,Axelson H,Panda CK,Babonits M,Ma A,Steinberg JM,Alt FW,Klein G,Wiener F

    更新日期:1992-06-01 00:00:00

  • Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.

    abstract::Intrinsic and acquired resistance to anti-EGFR antibody therapy, frequently mediated by a mutant or amplified KRAS oncogene, is a significant challenge in the treatment of colorectal cancer (CRC). However, the mechanism of KRAS-mediated therapeutic resistance is not well understood. In this study, we demonstrate that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0289-x

    authors: Knickelbein K,Tong J,Chen D,Wang YJ,Misale S,Bardelli A,Yu J,Zhang L

    更新日期:2018-08-01 00:00:00

  • The role of STATs in myeloid differentiation and leukemia.

    abstract::Myeloid differentiation is a highly regulated process governed by various cytokines, such as EPO, TPO, G-CSF, IL-3, IL-5 and GM-CSF. These cytokines act in part through activation of the STAT transcription factor family. In particular, various isoforms of STAT3 and STAT5 are activated during myeloid differentiation in...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203479

    authors: Coffer PJ,Koenderman L,de Groot RP

    更新日期:2000-05-15 00:00:00

  • Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.

    abstract::Procollagen lysyl hydroxylase 1 (PLOD1) is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer. Bioinformatics analysis revealed that PLOD1 is associated with the progression of GBM, particularly the most malignant mesenchymal subtype (MES). Moreover, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01635-y

    authors: Wang Z,Shi Y,Ying C,Jiang Y,Hu J

    更新日期:2021-01-08 00:00:00

  • Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.

    abstract::We studied loss of heterozygosity (LOH) in chromosome 7q in order to determine the location of a putative tumor suppressor gene (TSG) in human epithelial ovarian carcinomas. Samples were obtained from 26 primary ovarian carcinomas at the time of staging laparotomy. Paired normal and tumoral DNAs were used as templates...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zenklusen JC,Weitzel JN,Ball HG,Conti CJ

    更新日期:1995-07-20 00:00:00

  • Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.

    abstract::The motility of cancer cells in 3D matrices is of two types: mesenchymal motility, in which the cells are elongated and amoeboid motility, in which the cells are round. Amoeboid motility is driven by an actomyosin-based contractile force, which is regulated by the Rho/ROCK pathway. However, the molecular mechanisms un...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.2

    authors: Yamazaki D,Kurisu S,Takenawa T

    更新日期:2009-04-02 00:00:00

  • Microsatellite instability in prostate cancer.

    abstract::Assessment of the genetic instability of a microsatellite has indicated a new mechanism in human carcinogenesis. Examination was made to determine whether microsatellite instability is associated with the onset of prostate cancer. Twenty-nine DNA samples from 24 primary prostate cancer, two metastatic lymph-node and t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Uchida T,Wada C,Wang C,Ishida H,Egawa S,Yokoyama E,Ohtani H,Koshiba K

    更新日期:1995-03-02 00:00:00

  • Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation.

    abstract::Ras genes, frequently mutated in human tumors, promote malignant transformation. Ras transformation requires membrane anchorage, which is promoted by Ras farnesylcysteine carboxymethylester and by a second signal. Previously we showed that the farnesylcysteine mimetic, farnesylthiosalicylic acid (FTS) disrupts Ras mem...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204950

    authors: Paz A,Haklai R,Elad-Sfadia G,Ballan E,Kloog Y

    更新日期:2001-11-08 00:00:00

  • A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.

    abstract::Bcl-2 or Bcl-X(L) confers resistance to chemotherapy in multiple myeloma (MM). Here we characterized the effects of ABT-737, a potent small-molecule inhibitor of antiapoptotic proteins Bcl-2, Bcl-X(L) and Bcl-w with markedly higher affinity than previously reported compounds, on human MM cells. ABT-737 induces apoptos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210028

    authors: Chauhan D,Velankar M,Brahmandam M,Hideshima T,Podar K,Richardson P,Schlossman R,Ghobrial I,Raje N,Munshi N,Anderson KC

    更新日期:2007-04-05 00:00:00

  • The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.

    abstract::A cloned line of S + L- mink lung cells (A clone), which exhibited a flat morphology, was superinfected with a novel dual-tropic virus (E1BX-MuLV) showing a broad host range and a B-tropism. These cells gave rise to transformed cells with two phenotypes: those which were still anchorage-dependent (AD), and those which...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gao CL,Wang LC,Vass WC,Seth A,Chang KS

    更新日期:1988-09-01 00:00:00

  • TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.

    abstract::To achieve a better understanding of mechanisms that underlie hepatocarcinogenesis and to identify novel target molecules for diagnosis and therapy of hepatocellular carcinoma (HCC), we previously analysed gene-expression profiles of 20 HCC tissues on a cDNA microarray. Among the genes upregulated in the tumor tissues...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209517

    authors: Silva FP,Hamamoto R,Furukawa Y,Nakamura Y

    更新日期:2006-08-17 00:00:00

  • Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2.

    abstract::The RBTN1 and RBTN2 genes are activated by distinct translocations involving chromosome 11 in some T cell acute leukaemias. The RBTN proteins belong to the LIM family which comprises proteins with one, two or three cysteine-rich LIM domains, sometimes together with homeodomains or protein kinase domains. The RBTN1 and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sánchez-García I,Axelson H,Rabbitts TH

    更新日期:1995-04-06 00:00:00

  • Mutations of the p16 gene in gliomas.

    abstract::In the present study we investigated the frequency of p16 gene exon 2 mutations in 35 malignant gliomas, using either direct sequencing of the PCR products or cloning into the pCRII vector and sequencing of the cloned PCR products. No mutations were detected during direct sequencing of the PCR products. However, after...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kyritsis AP,Zhang B,Zhang W,Xiao M,Takeshima H,Bondy ML,Cunningham JE,Levin VA,Bruner J

    更新日期:1996-01-04 00:00:00

  • RFP represses transcriptional activation by bHLH transcription factors.

    abstract::Basic helix-loop-helix (bHLH) transcription factors play a pivotal role in the regulation of tumorigenesis, and also in a wide range of other developmental processes in diverse species from yeast to humans. Here we demonstrate for the first time that Ret finger protein (RFP), a member of the TRIM family of proteins in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208828

    authors: Bloor AJ,Kotsopoulou E,Hayward P,Champion BR,Green AR

    更新日期:2005-10-13 00:00:00

  • Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27.

    abstract::Many lines of evidence indicate that connexin genes expressing gap junction (GJ) proteins inhibit tumor cell proliferation. However, the precise molecular mechanisms remain unclear. In this study, we show that overexpression of connexin43 (Cx43) suppressed proliferation of human osteosarcoma U2OS cells through inhibit...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204563

    authors: Zhang YW,Morita I,Ikeda M,Ma KW,Murota S

    更新日期:2001-07-12 00:00:00

  • The human ryk cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain.

    abstract::The human ryk tyrosine kinase cDNA was originally identified as a PCR-amplified cDNA fragment (JTK5) from K562 leukemia cells and found to represent a ubiquitously expressed gene (Partanen et al., 1990). The open reading frame of human ryk, reported here, encodes a novel type of putative tyrosine kinase of 607 amino a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tamagnone L,Partanen J,Armstrong E,Lasota J,Ohgami K,Tazunoki T,LaForgia S,Huebner K,Alitalo K

    更新日期:1993-07-01 00:00:00

  • Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells.

    abstract::Expression level of metastasis-associated protein 1 (MTA1) is closely related to tumor growth and metastasis in various cancers. Although increased expression level of MTA1 was observed in hepatocellular carcinoma (HCC), role of MTA1 complex containing histone deacetylase (HDAC) in hepatitis B virus (HBV)-associated h...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211000

    authors: Yoo YG,Na TY,Seo HW,Seong JK,Park CK,Shin YK,Lee MO

    更新日期:2008-05-29 00:00:00

  • Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.

    abstract::Heat shock protein (Hsp)90 regulates many key pathways in oncogenesis, including Akt and mammalian target of rapamycin (mTOR). The strengths of disruption of Hsp90 in cancer therapy include their versatility in inhibiting a wide range of oncogenic pathways. The present study demonstrated that synuclein γ (SNCG) protec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.126

    authors: Liang W,Miao S,Zhang B,He S,Shou C,Manivel P,Krishna R,Chen Y,Shi YE

    更新日期:2015-04-30 00:00:00

  • Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.

    abstract::Like other types of pre-malignant lesions and carcinoma, angiogenesis is associated with high-grade cervical dysplasia and with invasive squamous carcinoma of the cervix. Vascular endothelial cell growth factor (VEGF) is known to be one of the most important inducers of angiogenesis and is upregulated in carcinoma of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203817

    authors: López-Ocejo O,Viloria-Petit A,Bequet-Romero M,Mukhopadhyay D,Rak J,Kerbel RS

    更新日期:2000-09-21 00:00:00

  • Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light.

    abstract::The tumor suppressor protein, p53, plays a critical role as a transcriptional activator of downstream target genes involved in the cellular response to DNA damaging agents. We examined the cell cycle checkpoint response of human mammary epithelial cells (HMEC) and their isogenic fibroblast counterparts to ionizing (IR...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202977

    authors: Meyer KM,Hess SM,Tlsty TD,Leadon SA

    更新日期:1999-10-14 00:00:00

  • MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.

    abstract::Wild-type p53 is stabilized and accumulates in the nucleus of DNA damaged cells. The effect of stabilizing p53 is to inhibit cell growth, either through a G1 cell cycle arrest or apoptotic cell death. MDM2 can inhibit p53 activity, in part, by promoting its rapid degradation through the ubiquitin proteolysis pathway. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203980

    authors: Yu ZK,Geyer RK,Maki CG

    更新日期:2000-11-30 00:00:00

  • Protein kinase D2: a versatile player in cancer biology.

    abstract::Protein kinase D2 (PKD2) is a serine/threonine kinase that belongs to the PKD family of calcium-calmodulin kinases, which comprises three isoforms: PKD1, PKD2, and PKD3. PKD2 is activated by many stimuli including growth factors, phorbol esters, and G-protein-coupled receptor agonists. PKD2 participation to uncontroll...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-017-0052-8

    authors: Azoitei N,Cobbaut M,Becher A,Van Lint J,Seufferlein T

    更新日期:2018-03-01 00:00:00

  • Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor.

    abstract::Granulocyte macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and interleukin-5 (IL-5 belong to a family of cytokines that regulate proliferation, differentiation and function of haematopoietic cells. Their receptor consists of a ligand specific alpha-chain and a signal transducing beta-chain (betac)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202896

    authors: Geijsen N,Spaargaren M,Raaijmakers JA,Lammers JW,Koenderman L,Coffer PJ

    更新日期:1999-09-09 00:00:00

  • Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways.

    abstract::Many of the signaling responses induced by transforming growth factor-beta (TGF-beta) are mediated by Smad proteins, but there is evidence that it can also signal independently of Smads. Here, we provide evidence that multiple signal pathways induced by TGF-beta1-including Src family tyrosine kinases (SFKs), generatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210649

    authors: Joo CK,Kim HS,Park JY,Seomun Y,Son MJ,Kim JT

    更新日期:2008-01-24 00:00:00